Top 50 Medical Device Startup Investors in China in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in China. We rank investors based on the number of investments they made in Medical device companies from China. We update this investor list every month.Top 50 Medical Device Startup Investors in China in October 2024
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
- Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
We help founders build enduring companies.
Show more
Investment focus
- Biotechnology, Health Care, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Australia
Portfolio highlights
- Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
- Sanshou Technology — Sanshou Technology focuses on researching and developing smart motorcycles.
- RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
- Feiduwei — Feiduwei specializes in researching and developing mixed digital and analog circuits, including signal chain and power-related chips.The devices are utilized in automotive electronics, industrial control, consumer electronics, and various other applications.
- Xingchen Optoelectronics — Xingchen Optoelectronics is dedicated to pushing the boundaries of existing laser communication payload solutions and fostering the development of high-speed satellite laser communication networks.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Targeting One — Targeting One is an in-vitro diagnostic product developer.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Angel, Series B
- China
Portfolio highlights
- MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
- Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.
Show more
Investment focus
- Manufacturing, Internet, Software
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- Infinigence — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
- Mihuo Intelligence — Mihuo Smart is a smart-home and appliance firm.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
- Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- Sentient — Community-built open AGI
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
- Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Series B, Funding Round
- China, Hong Kong, United States
Portfolio highlights
- Arthur Pharmaceuticals — Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer.
- Quail Fire Optoelectronics — Quailhuo Photovoltaic is a provider of solar power generation technology, specializing in the design and development of perovskite photovoltaic materials and battery component preparation technology.
- Suzhou Shensai New Materials — Suzhou Shensai New Materials manufacturers environmentally friendly clean foaming materials and other lightweight materials.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Pharmolix — Pharmolix is a biomedical company that focuses on the R&D and application of large models in the vertical industry of biomedicine.
- Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.
- Jichen Biotechnology — Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China
Portfolio highlights
- JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
- Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
- Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Medical Device, Biotechnology
- Series A, Angel, Seed
- China
Portfolio highlights
- Juhai Hengchuang — Juhai Hengchuang is a medical device manufacturer that exclusively sells and manufactures drug testing equipment.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
- Manufacturing, Medical, Biopharma
- Series A, Seed, Angel
- China
Portfolio highlights
- Fast Photonics — Fast Photonics specializes in the development and manufacturing of high-speed optical transceivers. The company offers a range of products designed for various applications in the field of optical communication. With a focus on innovation, Fast Photonics aims to provide solutions that meet the evolving needs of data transmission and communicationnetworks. The company holds ISO certification, emphasizing its commitment to quality and standards in manufacturing processes. Fast Photonics serves as an OEM/ODM/JDM partner, offering customized solutions to meet specific customer requirements. The company's expertise in optical technology makes it a key player in the industry, catering to the demands for faster and more efficient data communication.
- REEM Healthcare — REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medicaldevices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.
- Ruigu New Materials — Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more
Investment focus
- Health Care, Manufacturing, Medical
- Series A, Series B, Angel
- China
Portfolio highlights
- Shenglei Technology — Shenglei Technology manufactures engineering products and offers laser ultrasonic testing services.
- Guancheng Information — Guancheng Information is a competent provider of comprehensive intelligent industrial solutions. It focuses on the medical device and high-technology electronics industries.
- Xinshinuo Semiconductor — Xinshinuo Semiconductor is a domestic semiconductor equipment and technology company.
SZHTI Group is a company that provides asset management and financing services.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Angel, Funding Round
- China, United States
Portfolio highlights
- Light Future — Light Future is a complete metal additive manufacturing solutions provider for the industrial market. It is dedicated to speeding up the global industrialization of metal additive manufacturing technology and focuses on all-inclusive solutions for industrial-grade metal additive manufacturing. This will enable additive manufacturing technology tobecome truly inclusive for industrial use.
- Ruibo Automation — Ruibo Automation is a high-tech inventive firm that specializes in Press-Fit pin process automation equipment. It combines independent research and development, manufacturing, and sales.
- Xiaoyao Technology — Xiaoyao Technology is an optoelectronic chip design automation.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
- Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
- Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- China, United States, Hong Kong
Portfolio highlights
- Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
- Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
- Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Yida Technology — SaaS, Data
- Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more
Investment focus
- Manufacturing, Information Technology, Health Care
- Series A, Series B, Series C
- China, Japan, United States
Portfolio highlights
- GZTech — GZTech is a technology company that specializes in the development, production, and sale of advanced industrial lasers and light sources for precision.
- Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
- Zhongke Ruijian — Zhongke Ruijian is a counterfeit detection platform that aims to empower digital content security by using AI technology to detect false information and forgery tracing for many fields.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
- Artificial Intelligence, Biotechnology, Medical
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- Polycent — Polycent, a technology company with expertise in power technology, industrial control, data intelligence, and FPGA, develops digital power solutions using advanced electrical, sensing, and algorithm technologies, accelerating industrialization and high-quality power system development.
- Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
- Hangkai Microelectronics — Hangkai MicroTech focuses on the research, development, and manufacturing of Mems technology and products, with an emphasis on the demand for domestic sensor substitutes.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
- Xinshi Technology — Xinshi Technology is the developer of semiconductor front-end measurement and testing equipment.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Insight Capital is a venture capital firm focused on early-stage investment.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- China
Portfolio highlights
- Amity — Discover Amity, where we create digital solutions that help organizations, teams and individuals achieve more through technology and social innovation.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Angel
- China
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
- Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
- Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
BIOCHING CAPITAL is an investment management firm.
Show more
Investment focus
- Medical Device, Medical, Biopharma
- Angel, Seed
- China
Portfolio highlights
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
- Thorough Future — Using big data and artificial intelligence to provide pathology images with intelligent discriminations, diagnosis, prediction.
- Aoli Biotechnology — Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- RootData — RootData operates as a Web3 asset data platform that pioneers in encapsulating both on-chain and off-chain data of Web3 assets.
- Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
- weshare — Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide throughcontinuous exploration and technologies.
Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.
Show more
Investment focus
- Software, E-Commerce, Artificial Intelligence
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
- Zhihe Computing — Zhihe Computing is an AI intelligent computing company that develops high-performance, scalable AI intelligent computing CPUs and RISC-V processors.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Show more
Investment focus
- Manufacturing, Semiconductor, Health Care
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Metrono — Metrono is a manufacturer of cable and optical cable that provides high-performance rail transit special cable solutions and supplies a full range of European standard locomotive cables.
- Da Instruments — Da Instruments is a technology company that specializes in satellite communications and automotive electronics test and measurement solutions.
- Qingyan Haolong New Energy — Qingyan Haolong New Energy manufactures PTC heating film products that are designed for new energy lithium battery thermal management systems.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
- Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
- Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China
Portfolio highlights
- Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
- Inflamax Pharmaceuticals — Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.
- EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series B, Seed, Series A
- China
Portfolio highlights
- EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
- PulseCare — PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
- Deco Medical — Deco Medical is a myocardial repair service provider and an innovative medical device research and development enterprise.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, Singapore, United States
Portfolio highlights
- Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
- Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A, Series B, Angel
- China, United States
Portfolio highlights
- Filan Air — Filan Air develops technology for improving air quality, such as air treatment for medical laboratories.
- Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
- Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
Qingrong Ventures is an Investment firm.
Show more
Investment focus
- Medical, Medical Device, Health Care
- Seed, Angel
- China
Portfolio highlights
- BrainThink — BrainThink integrates wearable sensors to deliver scalp electroencephalogram (EEG) and heart rate variability (HRV). BrainThink provides fast assessment for depression, anxiety, motor imagery, and attention.
- Yuansheng Intelligence — Yuansheng Intelligence is a manufacturer of intricate rehabilitation and nursing medical hardware.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Angel
- China, United States, Hong Kong
Portfolio highlights
- Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
- Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
- Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more
Investment focus
- Health Care, Biotechnology, Manufacturing
- Series A, Series B, Series C
- China, United States
Portfolio highlights
- Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
- Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
- Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
Green Pine Capital Partners is a venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Manufacturing, Software
- Series A, Angel, Series B
- China, United States, Canada
Portfolio highlights
- Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
- Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
- Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Seed, Angel
- China, United States
Portfolio highlights
- Xinhong life — Xinhong Life is a technologically creative medical company dedicated to developing a medical enterprise based on ultrasound energy technology as well as combining drug and device technology. Xinhong Life, which specializes in interventional ultrasound technology and combined drug-device technology, has developed a number of technology platforms,including interventional ultrasound energy technology, combined drug-device technology, software and algorithm architecture technology, and industrial transformation platforms, and continues to develop innovative energy device products that truly address clinical pain points.
- Guiyan Electronic — Guiyan Electronic is an electronic materials company that specializes in the development and innovation of silicon nanomaterials.
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Yunnan Bethany Biotechnology is a healthcare company that manufactures skin care products for sensitive skin, acne, barrier damage, stubborn spots, and fragile skin. They provide a scientific care programs for certain skin problems and develop effective and safe skin care products.
Show more
Investment focus
- Medical, Medical Device, Health Care
- Series A, Corporate Round
- China
Portfolio highlights
- Weimu Medical — Weimu Medical is a high-end interventional medical device developer.
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
- Ruishi Technology — Ruishi Technology develops Myopia prevention and control medical devices.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
- Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
- Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Jinding Capital is a leading industrial equity investment institution in China.
Show more
Investment focus
- Manufacturing, Health Care, Pet
- Series A, Series B, Seed
- China
Portfolio highlights
- Robot era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
- Jinjing Keji — Jinjing Keji manufactures cathode fluorescence system products. They are mainly in scientific research institutes, semiconductor industry, and electron microscope manufacturing. They provide testing services too in addition to selling the product.
- Shengzhi Runhe — Shengzhi Runhe is a producer of medical and aesthetic regeneration materials. It is committed to being a technology innovator and primary service provider in the anti-aging field of regenerative biomaterials.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Social Media
Web3
Medical
Email
Clean Energy
Art
Wellness
Music
Mobile
Oil and Gas
Franchise
Social Network
Video Games
Local
Internet
Digital Media
Construction
Manufacturing
eSports
Food and Beverage
Sports
Enterprise Software
Legal
Publishing
Android
Platforms
Education
Mobile Advertising
Payments
Biotechnology
Hospitality
Fashion
Fitness
Travel
Organic Food
Recruiting
Cannabis
Retail
Wine And Spirits
Medical Device
Crowdfunding
Financial Services
Social
Automotive
Infrastructure
CleanTech
Transportation
InsurTech
Mobile Apps
Enterprise
SaaS
LGBT
Life Science
Theatre
Film
Non Profit
Renewable Energy
Sporting Goods
Restaurants
Social Impact
Agriculture (agtech)
Software
Celebrity
Cryptocurrency
Media (entertainment)
Blockchain
Facebook
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Morocco
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Malta
Estonia
Hong Kong
Denmark
Mali
Gibraltar
Malaysia
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Italy
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Peru
Croatia
Bulgaria
Bahrain
Lithuania
Turkey
Myanmar
Serbia
Rwanda
Lebanon
El Salvador
Kuwait
Venezuela
Cayman Islands
Ukraine
Cambodia
Portugal
Israel
Sierra Leone
Panama
Zimbabwe
Sweden
Taiwan
Mexico
Senegal
Kazakhstan
Uruguay
Liberia
Jersey
Uganda
Philippines
Tunisia
San Marino
Slovenia
Norway
Zambia
Uzbekistan
Russian Federation
Mauritius
Seychelles
Kenya
Thailand
Puerto Rico
Liechtenstein
Tajikistan
Togo
Poland
Nicaragua
Tanzania
Dominican Republic
United Arab Emirates
Nigeria
Azerbaijan
Namibia
Iceland
Iraq
Bahamas
Honduras
Luxembourg
Bolivia
Isle of Man
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in China by industry
Restaurants
Crowdfunding
Venture Capital
Film
Retail
Publishing
Financial Services
Real Estate
Cryptocurrency
Finance
Food and Beverage
Wine And Spirits
Medical
Organic Food
Medical Device
Wellness
Biotech
Art
Digital Media
Blockchain
Music
Mobile
Android
Non Profit
Social Media
Legal
Software
Construction
Social Network
Local
Enterprise Software
Video Games
eSports
InsurTech
CleanTech
Payments
Travel
Hospitality
Automotive
Mobile Advertising
Platforms
FinTech
Biotechnology
Enterprise
Health Care
EdTech
Climate
Energy
Sustainability
Impact
Proptech
SaaS
Marketplace
Community
Hardware
Gaming
Social
Infrastructure
Beauty
Fashion
Web3
B2B
Life Science
Sporting Goods
Photography
Big Data
Clean Energy
Education
Oil and Gas
Renewable Energy
Fitness
Mobile Apps
Consumer
Recruiting
Internet
Agriculture (agtech)
Manufacturing
Media (entertainment)
Sports
Artificial intelligence
Transportation